The McGill International TB Centre (MITBC) is made up of McGill researchers with an interest in TB, as well as Canadian and international researchers with an active collaboration with a MITBC member.
MITBC members and affiliate members have wide ranging expertise in different disciplines and methodologies. Their research projects range from basic biomedical research to population and policy level studies. Their research may be considered to span a spectrum of disciplines of health research.
MITBC Executive Committee
Dick Menzies - Director
Dr. Dick Menzies received his medical training at McGill University and specialty training in Internal Medicine at the Medical College of Pennsylvania in Philadelphia, USA, with sub-specialty training in Respiratory Medicine and a Master’s degree in Epidemiology & Biostatistics at McGill University. He is now Director of the McGill WHO Collaborating Centre in TB Research and the McGill International TB Center.
Marcel Behr
Dr. Marcel Behr is a clinician-scientist. He trained at the University of Toronto, Queen's, McGill and Stanford. He was the founding Director of the McGill International TB Centre and led it from 2012 to 2018. He is Director of the McGill Infectious Diseases Division and the McGill Interdisciplinary Initiative in Infection and Immunity (MI4).
Jonathon Campbell
Dr. Jonathon Campbell received his PhD from the University of British Columbia in 2018 and completed a postdoctoral fellowship at McGill University. His research centers on generating evidence to inform the design and implementation of novel tuberculosis prevention and care strategies that maximize public health impact, while minimizing health system and patient costs.
Maziar Divangahi
Dr. Maziar Divangahi is a Professor of Medicine at McGill University. Dr. Divangahi is the Associate Director of the Meakins-Christie Laboratories. He is an internationally recognized pulmonary immunologist and the overarching focus of his research program is to investigate the regulatory mechanisms involved in host resistance and disease tolerance against major pulmonary bacterial pathogens.
Olivia Oxlade - Associate Director
Olivia Oxlade trained as an epidemiologist at the London School of Hygiene and Tropical Medicine (MSc in Control of Infectious Disease) and McGill University (PhD in Epidemiology). After completing her PhD, Dr. Oxlade conducted research and worked at the RI-MUHC on projects related to tuberculosis, social determinants of health, health system strengthening and decision analysis.
Erwin Schurr
Dr. Erwin Schurr is a Distinguished James McGill Professor of Human Genetics and Medicine at McGill University. He is the past leader of the Program of Infectious Diseases and Immunity in Global Health (IDIGH) at the Research Institute of the McGill University Health Centre.
